The following is a list of briefings, documents, and publications that have been ranked by the Alliance for Health Reform in
order of relevance, 10 being "Exclusively Related" to the issue, to 5 being "Somewhat Related" to the issue.
Webcasts, transcripts and resource materials can be downloaded for each briefing listed.
|
| Rank | Type | Description |
| 10 | Briefing | Pharmaceutical Policy and Pricing: Are Other Countries Getting Greater Value?, 11/7/2011 Spending on prescription drugs in the U.S. rose at a faster clip in 2009 than spending for hospital and physician care, a trend that is expected to continue through 2020. Thus, federal and state budget cutters – as well as private health plans and hospitals – have a keen interest in restraining drug costs. The desire to get a handle on drug spending is a focus in other countries as well. What are some strategies used in other countries to control pharmaceutical spending? How are value-based models being used by insurers and others to influence pharmaceutical utilization and health outcomes? How do the public and private sectors in the United States seek to contain pharmaceutical spending? To address these and related questions, the Alliance for Health Reform and The Commonwealth Fund are sponsoring a November 7 luncheon briefing.
|
| 10 | Briefing | Reviewing Prescription Drug Coverage:
Policies and Practices Across Several Health Systems, 6/23/2006 The Medicare prescription drug program offers coverage for prescription drugs through competing private plans, within a framework established by law and through rules established by the Centers for Medicare and Medicaid Services. In contrast, other countries, including Australia, the UK, and Canada, provide similar prescription drug programs, but within different regulatory structures. How do these countries decide which drugs will be approved and included in their prescription drug programs for the elderly and disabled?
|
| 10 | Document | Spatz Presentation, 11/7/2011 (PowerPoint: 642 kb)
|
| 10 | Document | Hess Presentation, 11/7/2011 (PowerPoint: 450 kb)
|
| 10 | Document | Dillon Presentation, 11/7/2011 (PowerPoint: 404 kb)
|
| 10 | Document | Harousseau Presentation, 11/7/2011 (PowerPoint: 1,060 kb)
|
| 10 | Other Publication | Sourcebook 2004 - Chapter 6: Prescription Drugs, 9/1/2004 This chapter from the Alliance sourcebook, “Covering Health Issues, 2004” presents key facts, background, story ideas, experts and websites on the subject of prescription drugs. (Adobe Acrobat PDF: 2,430 kb)
|
| 10 | Offsite Document | U.S. drug spending slows; hits $307 bln in 2010: report, 4/19/2011 - Source: Reuters (Unknown File Type)
|
| 10 | Offsite Document | Seniors Feeling the Squeeze: Rising Drug Prices and the Part D Program, 3/17/2010 - Source: American Enterprise Institute (Unknown File Type)
|
| 10 | Offsite Document | The World Medicines Situation 2011, 1/1/2011 - Source: World Health Organization (Unknown File Type)
|
| 10 | Offsite Document | At Pitney Bowes, Value-Based Insurance Design Cut Copayments and Increased Drug Adherence, 11/2/2010 - Source: The Commonwealth Fund (Unknown File Type)
|
| 10 | Offsite Document | US Pharmaceutical Policy In A Global Marketplace, 12/16/2008 - Source: Health Affairs Adobe Acrobat PDF
|
| 10 | Offsite Document | Comparative Effectiveness Review Within the U.K.’s National Institute for Health and Clinical Experience, 7/1/2009 - Source: The Commonwealth Fund Adobe Acrobat PDF
|
| 10 | Offsite Document | Projecting future drug expenditures – 2009, 2/1/2009 - Source: American Journal of Health-System Pharmacy (Unknown File Type)
|
| 10 | Offsite Document | Drug program saves state millions – but more can be done, 11/1/2011 - Source: The Olympian (Unknown File Type)
|
| 10 | Offsite Document | Ending drug companies’ pay-for-delay deals, 10/24/2011 - Source: The Washington Post (Unknown File Type)
|
| 10 | Offsite Document | Descriptions of Health Care Systems: England, France, and Germany, 12/31/2011 - Source: The Commonwealth Fund (Unknown File Type)
|
| 10 | Offsite Document | Multinational Comparisons of Health Systems Data, 2011, 12/31/2011 - Source: The Commonwealth Fund (Unknown File Type)
|
| 10 | Offsite Document | Prescription Drug Accessibility and Affordability in the United States and Abroad, 6/1/2010 - Source: The Commonwealth Fund Adobe Acrobat PDF
|
| 10 | Offsite Document | National Authority for Health: France, 7/31/2009 - Source: The Commonwealth Fund (Unknown File Type)
|
| 10 | Offsite Document | Institute for Quality and Efficiency in Health Care: Germany, 7/1/2009 - Source: The Commonwealth Fund Adobe Acrobat PDF
|
| 10 | Offsite Document | The National Institute for Health and Clinical Excellence (NICE), 2011, 12/31/2011 - Source: The National Institute for Health and Clinical Excellence (Unknown File Type)
|
| 10 | Offsite Document | National Authority for Health: France, 7/1/2009 - Source: The Commonwealth Fund (Unknown File Type)
|
| 10 | Offsite Document | Prescription Drug Trends, 5/31/2011 - Source: Kaiser Family Foundation Adobe Acrobat PDF
|
| 10 | Offsite Document | Lower-Than-Expected Medicare Drug Costs Reflect Decline in Overall Drug Spending and Lower Enrollment, Not Private Plans, 5/6/2011 - Source: Center on Budget and Policy Priorities (Unknown File Type)
|
| 10 | Offsite Document | Consumer groups: Obama more generous to Big Pharma in trade talks, 10/24/2011 - Source: Healthwatch (Unknown File Type)
|
| 9 | Briefing | BALANCING THE PROMISE AND COST OF BIOTECHNOLOGY
, 9/22/2006 Biotechnology accounts for only one percent of insurers’ costs, but those costs are growing at a double digit rate. As science produces increasingly sophisticated and expensive medical products and procedures based on the manipulation of living organisms, payers will increasingly struggle with managing their use.
|
| 9 | Briefing Transcript | Transcript, 11/7/2011 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 247 kb)
|
| 9 | Document | Materials List, 11/7/2011 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 44 kb)
|
| 9 | Document | Source List, 11/7/2011 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 94 kb)
|
| 9 | Document | Agenda, 11/7/2011 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 19 kb)
|
| 9 | Document | Speaker Bios, 11/7/2011 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 16 kb)
|
| 9 | Briefing Transcript | Transcript: Balancing the Cost and the Promise of Biotechnology, 9/22/2006 (Adobe Acrobat PDF: 195 kb)
|
| 9 | Briefing Transcript | Reviewing Prescription Drug Coverage, 6/23/2006 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 227 kb)
|
| 9 | Document | Steven Morgan Presentation: Well-Designed Drug Review Processes Can Improve Drug Coverage, 6/23/2006 - Source: Centre for Health Services and Policy Research, U. of British Columbia (Adobe Acrobat PDF: 383 kb)
|
| 9 | Document | Libby Roughead Presentation: Australia's National Medicines Policy, 6/23/2006 - Source: University of South Australia (Adobe Acrobat PDF: 9,267 kb)
|
| 9 | Document | P. Kanavos Presentation: The European Experience in Drug Policy, Efficiency & Cost Containment, 6/23/2006 - Source: London School of Economics (Adobe Acrobat PDF: 485 kb)
|
| 9 | Document | Tanisha Carino Presentation: The U.S. Perspective - Medicare Part D, 6/23/2006 - Source: Avalere Health (Adobe Acrobat PDF: 245 kb)
|
| 9 | Document | Australia's Nat'l Medicines Policy: Providing an Integrated Policy Platform for Pharmaceuticals, 6/23/2006 - Source: Elizabeth Roughead, University of South Australia School of Pharmacy and Medical Sciences (Word Document: 104 kb)
|
| 9 | Document | Policy Approaches to Pharmaceutical Pricing and Reimbursement in European Countries, 6/23/2006 - Source: Panos Kanavos, London School of Economics and Political Science (Word Document: 107 kb)
|
| 9 | Document | Centralized Drug Review in Australia, Canada, New Zealand and the United Kingdom, 6/23/2006 - Source: Steven Morgan, University of British Columbia (Word Document: 74 kb)
|
| 9 | Document | Medicare's New Adventure: the Part D Drug Benefit, 3/1/2006 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 133 kb)
|
| 9 | Briefing Transcript | The Reality and Potential of Evidence-Based Medicine, 1/12/2006 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 193 kb)
|
| 9 | Briefing Transcript | Weighing the Evidence: Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 211 kb)
|
| 9 | Document | Sourcelist: The Reality and Potential of Evidence-Based Medicine, 1/12/2005 - Source: Alliance for Health Reform (Word Document: 28 kb)
|
| 9 | Document | Gail Shearer Presentation: Bringing Evidence-Based Medicine to Consumers, 1/12/2005 - Source: Consumers Union (PowerPoint: 2,308 kb)
|
| 9 | Offsite Document | Centralized Drug Review Processes in Australia, Canada, New Zealand, and the United States, 4/1/2006 - Source: Health Affairs (Unknown File Type)
|
| 9 | Offsite Document | Evidence-Based and Value-Based Formulary Guidelines, 2/1/2004 - Source: Health Affairs (Unknown File Type)
|
| 9 | Offsite Document | The Efficient Use of Pharmaceuticals: Does Europe Have Any Lessons for a Medicare Drug Benefit?, 6/1/2003 - Source: Health Affairs (Unknown File Type)
|
| 9 | Offsite Document | Herceptin - UK Employers Should Prepare for Rise in Healthcare Costs, 6/22/2006 - Source: Mercer Human Resource Consulting (Unknown File Type)
|
| 9 | Offsite Document | Effective Health Care, 1/1/2006 - Source: Agency for Healthcare Research and Quality (Unknown File Type)
|
| 9 | Offsite Document | Drug Effectiveness Review Project, 1/1/2006 - Source: Oregon Health and Science University (Unknown File Type)
|
| 9 | Offsite Document | Comparative Effectiveness of Treatments for Low Bone Density (Including Osteoporosis), 1/1/2006 - Source: Agency for Healthcare Research and Quality Adobe Acrobat PDF
|
| 9 | Offsite Document | Europe's Ailing Drug Industry, 12/28/2005 - Source: Galen Institute (Unknown File Type)
|
| 9 | Offsite Document | Navigating the Medicare Part D Prescription Drug Coverage Program, 6/14/2006 - Source: United Cerebral Palsy (Unknown File Type)
|
| 9 | Offsite Document | Pharmaceutical Pricing Policies and Innovation, 1/1/2006 - Source: Organisation for Economic Co-operation and Development (Unknown File Type)
|
| 9 | Offsite Document | FDA Drug Review Set to Unravel as Fiscal Cliff Looms, 9/10/2012 - Source: Bloomberg (Unknown File Type)
|
| 9 | Offsite Document | September Sequester Surprise? Impact of the OMB Sequester Report of FDA User Fees, 9/14/2012 - Source: Faegre Baker Daniels (Unknown File Type)
|
| 9 | Offsite Document | Q&As about the NIMH Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study , 3/23/2006 - Source: National Institute of Mental Health (Unknown File Type)
|
| 9 | Offsite Document | Q&As about the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness Study (CATIE), 9/1/2005 - Source: National Institute of Mental Health (Unknown File Type)
|
| 8 | Briefing | Private Financing and High-level Functioning: Some International Approaches to Health Reform, 4/11/2008 While the United States delivers some of the best medical care in the world, there are major inefficiencies in our system. We have high rates of medical errors, millions without health insurance coverage, and lower utilization of advanced health information technology than most western European nations. What can we learn about coverage patterns and health care costs in other countries that might help inform our choices in the U.S.? This briefing, cosponsored by The Commonwealth Fund, addressed these and related questions.
|
| 8 | Briefing | Health Legislation 2007-2008: What's Possible?, 12/13/2006 Suddenly, Capitol Hill is talking about health issues again. Incoming House Speaker Nancy Pelosi promises that Democrats will roll back the prohibition against the federal government negotiating drug prices on behalf of Medicare beneficiaries. (A Kaiser Family Foundation poll released today found broad bipartisan support for this idea.) Incoming Senate Majority Leader Harry Reid says one of his three top priorities will be more funding for stem cell research. Others want to revisit the importation of prescription drugs from Canada. Additionally, the 110th Congress will consider whether to continue the State Children’s Health Insurance Program in its present form.
|
| 8 | Briefing | Making Sense of Medicare's Drug Benefit: Information and Resources to Help Beneficiaries, 11/7/2005 To help understand the basics of the new Medicare prescription drug benefit, the nonpartisan Alliance for Health Reform and the Kaiser Family Foundation held a briefing especially for congressional staff, including district and state staff, but also of interest to others. Panelists were Tricia Neuman of the Kaiser Family Foundation’s Medicare Policy Project; Jack Vogelsong of Pennsylvania’s State Health Insurance and Assistance Program; Beatrice Disman of the New York Region of the Social Security Administration; and Julie Goon of the Centers for Medicare and Medicaid Services.
|
| 8 | Briefing | Implementing the Medicare Drug Benefit: The Stories Ahead, 9/27/2005 Medicare beneficiaries can start signing up for prescription drug plans on November 15. Already, health plans have announced that they will be spending up to $80 million each to promote their offerings. The federal government and nonprofit groups are well into a massive effort to educate the public. But beneficiaries and those they rely on still have many questions about the program. The Alliance for Health Reform sponsored a briefing on Sept. 27 to help reporters with their coverage of the new benefit's implementation and offer story ideas.
|
| 8 | Briefing | WEIGHING THE EVIDENCE: Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005 Publicly funded health programs, large employers and managed care plans all are working to learn more about how the costs and benefits of one drug compare with those of another. At the same time, these payers of health care want to make sure that their beneficiaries have access to new pharmaceuticals that offer measurable improvements over older products. What evidence gets reviewed in deciding (or recommending) whether a drug gets covered? How open to public scrutiny is the review process? Which stakeholders are most closely involved? Are decisions ever revisited or reversed? How do review methods differ among different countries?
|
| 8 | Briefing | The Reality and Potential of Evidence-Based Medicine, 1/12/2005 Evidence-based medicine offers a win-win proposition: improve the quality and effectiveness of care while at the same time identifying opportunities to reduce waste of valuable health care resources. But what evidence should employers, health care providers and consumers pay attention to? And how should this information be disseminated to those who need it?
|
| 8 | Document | Using Clinical Evidenceto Manage Pharmacy Benefits: Experiences of Six States, 3/1/2007 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 133 kb)
|
| 8 | Document | Robinson Presentation: Balancing the Promise and Cost of Biotechnology, 9/22/2006 (Adobe Acrobat PDF: 81 kb)
|
| 8 | Document | Tunis Presentation: Balancing the Promise and Cost of Biotechnology, 9/22/2006 (Adobe Acrobat PDF: 168 kb)
|
| 8 | Document | Sourcelist: Reviewing Prescription Drug Coverage, 6/23/2006 - Source: Alliance for Health Reform (Word Document: 41 kb)
|
| 8 | Briefing Transcript | Making Sense of Medicare's Drug Benefit, 11/7/2005 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 208 kb)
|
| 8 | Document | Tricia Neuman Presentation: The Medicare Prescription Drug Benefit, 11/7/2005 - Source: Kaiser Family Foundation (Adobe Acrobat PDF: 75 kb)
|
| 8 | Document | Sourcelist: Weighing the Evidence- Conducting Reviews of Pharmaceuticals in Four Countries, 4/22/2005 - Source: Alliance for Health Reform (Word Document: 31 kb)
|
| 8 | Offsite Document | Principles for Govt-Supported Health Outcomes Research on Medical Technologies & Services, 1/1/2006 - Source: PhRMA (Unknown File Type)
|
| 7 | Document | Medication Errors Injure 1.5 Million People and Costs Billions of Dollars Annually, 7/20/2008 - Source: Institute of Medicine (Adobe Acrobat PDF: 25 kb)
|
| 7 | Document | Letter to Baucus, 5/22/2008 - Source: Various Drugstore Chains (Adobe Acrobat PDF: 116 kb)
|
| 7 | Document | Medicare Part D Fact Sheet, 10/29/2007 - Source: Kaiser Family Foundation (Adobe Acrobat PDF: 332 kb)
|
| 7 | Document | Tracking Medicare Health and Prescription Drug Plans - Monthly Report for September 2007, 10/10/2007 - Source: Kaiser Family Foundation and Mathematica Policy Research, Inc. (Adobe Acrobat PDF: 42 kb)
|
| 7 | Document | 2007 State of the Union Policy Initiatives: Affordable, Accessible, And Flexible Health Covera, 1/1/2007 - Source: The White House (Word Document: 50 kb)
|
| 7 | Document | Comparitive Effectiveness Forum: Executive Summary, 11/30/2006 - Source: The Health Industry Forum (Adobe Acrobat PDF: 465 kb)
|
| 7 | Document | Drug Money, 6/16/2006 - Source: Christopher Gallen, Canadian Business (Word Document: 30 kb)
|
| 7 | Document | CMS Sets $500 Threshold for Specialty Tiers, 4/1/2006 - Source: Medicare Drug Reimbursement Guide (Adobe Acrobat PDF: 393 kb)
|
| 7 | Document | Australia's Centralized Cost-Effectiveness Requirement for Pharmaceuticals, 1/1/2006 - Source: IMS Consulting (Adobe Acrobat PDF: 139 kb)
|
| 7 | Document | 418 Biotechnology Medicines in Testing Promise to Bolster the Arsenal Against Disease, 1/1/2006 - Source: Pharmaceutical Research and Manufacturers Association (PhRMA) (Adobe Acrobat PDF: 254 kb)
|
| 7 | Document | As biotech drug prices rise, U.S. hunts for solution, 12/28/2005 - Source: Geeta Anand, The Wall Street Journal (Word Document: 45 kb)
|
| 7 | Document | Julie Goon Presentation: CMS Information and Resources for the Medicare Drug Benefit, 11/7/2005 - Source: CMS (Adobe Acrobat PDF: 1,271 kb)
|
| 7 | Document | Sourcelist: Making Sense of Medicare's Drug Benefit, 11/7/2005 - Source: Alliance for Health Reform (Word Document: 61 kb)
|
| 7 | Document | Sourcelist: Implementing the Medicare Drug Benefit, 9/27/2005 - Source: Alliance for Health Reform (Word Document: 101 kb)
|
| 7 | Briefing Transcript | Implementing the Medicare Drug Benefit, 9/27/2005 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 164 kb)
|
| 7 | Document | Mark Benoff Presentation: Implementing the Medicare Drug Benefit, 9/27/2005 - Source: Cambridge Pharma Consultancy (Adobe Acrobat PDF: 126 kb)
|
| 7 | Document | 2005 International Symposium on Health Care Policy: Descriptions of Health Care Systems, 1/1/2005 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 136 kb)
|
| 7 | Offsite Document | Consumer Reports Medical Website Gives Evidence & Treatment Ratings to Make Informed Decisions, 5/17/2005 - Source: Consumer Reports (Unknown File Type)
|
| 7 | Offsite Document | Frist Highlights AHRQ's Efforts to Improve Quality of Health Care, 2/9/2006 - Source: Bill Frist, M.D. United States Senator, Tennessee (Unknown File Type)
|
| 7 | Offsite Document | Minnesota Mandates E-Prescribing, 6/3/2008 - Source: Health Data Management (Unknown File Type)
|
| 7 | Offsite Document | Developing a Center for Comparative Effectiveness Information, 11/1/2006 - Source: Health Affairs (Unknown File Type)
|
| 7 | Offsite Document | Consumer Reports: Best Buy Drugs, 4/27/2007 - Source: Consumer Report (Unknown File Type)
|
| 7 | Offsite Document | Drug Effectiveness Review, 4/27/2007 - Source: Oregon Health Science University (Unknown File Type)
|
| 7 | Offsite Document | Medicare Part D: Assessing the Impact for Beneficiaries Without Prev Drug Coverage and Dual Eli, 9/1/2007 - Source: PhRMA Adobe Acrobat PDF
|
| 7 | Offsite Document | Medicare Part D Chartpack, 11/7/2007 - Source: Kaiser Family Foundation (Unknown File Type)
|
| 7 | Offsite Document | Medicare Part D 2008 Data Spotlights, 11/7/2007 - Source: Kaiser Family Foundation (Unknown File Type)
|
| 6 | Briefing | Prospects for Health Care: Where Will New Congressional Leadership Take Us?, 12/8/2006 Come January, we can expect to see some new approaches to health legislation. Sen. Harry Reid, incoming Senate majority leader, says one of his top three priorities will be more funding for stem cell research. House Speaker-to-be Nancy Pelosi wants a vote early on to roll back the prohibition against the federal government negotiating prescription drug prices for Medicare beneficiaries. And these are just two of the health issues likely to be debated in the new Congress. The White House too will have a definite voice in the debates to come.
|
| 6 | Document | The Power of Partnerships: Lessons from Outreach for the Part D Low-Income Subsidy Program, 9/1/2007 - Source: Kaiser Permanente (Adobe Acrobat PDF: 554 kb)
|
| 6 | Document | AHIP Statement on Medicare Part D, 1/1/2007 - Source: America's Health Insurance Plans (Adobe Acrobat PDF: 66 kb)
|
| 6 | Briefing Transcript | What Other Nations Can Teach Us About A More Patient Centered Health Care System, Part I, 11/4/2006 - Source: Kaisernetwork.org (Adobe Acrobat PDF: 143 kb)
|
| 6 | Briefing Transcript | What Other Nations Can Teach Us About A More Patient Centered Health Care System, Part II, 11/4/2006 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 110 kb)
|
| 6 | Briefing Transcript | What Other Nations Can Teach Us About A More Patient Centered Health Care System, Part III, 11/4/2006 - Source: Alliance for Health Reform (Adobe Acrobat PDF: 132 kb)
|
| 6 | Document | Health Care Opinion Leaders Survey: Medicare Part D, 7/6/2006 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 63 kb)
|
| 6 | Document | New Study Captures Variations Across Medicare Drug Plans, 4/11/2006 - Source: Kaiser Family Foundation (Word Document: 56 kb)
|
| 6 | Document | The U.S. Health Care Divide: Disparities in Primary Care Experiences by Income, 4/1/2006 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 216 kb)
|
| 6 | Document | Mirror, Mirror on the Wall: Update on the Quality of American Health Care , 4/1/2006 - Source: The Commonwealth Fund (Adobe Acrobat PDF: 191 kb)
|
| 6 | Document | The Rise and Role of Specialty Pharmacies, 10/1/2005 - Source: David Suchanek, Biotechnology Healthcare (Adobe Acrobat PDF: 114 kb)
|
| 6 | Document | Aetna Letter: Health Savings Accounts - Exceptions for Preventive Prescription Drugs, 5/25/2005 - Source: Aetna (Adobe Acrobat PDF: 325 kb)
|
| 6 | Offsite Document | Taking the Pulse of Health Care Systems: Experiences of Patients in Six Countries, 11/3/2005 - Source: Health Affairs (Unknown File Type)
|
| 6 | Offsite Document | Average Medicare Prescription Drug Premiums to Rise 21%, 10/5/2007 - Source: Avalere Health (Unknown File Type)
|
| 6 | Offsite Document | Squeezed: Why Rising Exposure to Health Care Costs Threatens the Health and Financial Well-Bein, 10/1/2006 - Source: The Commonwealth Fund (Unknown File Type)
|
| 6 | Offsite Document | Electronic Prescribing: Becoming a Mainstream Practice, 6/10/2008 - Source: eHealth Initiative and Center for improving Medication Management Adobe Acrobat PDF
|
| 6 | Offsite Document | E-prescribing Campaign Aims at Patients to Reach Doctors, 6/2/2008 - Source: American Medical News (Unknown File Type)
|
| 6 | Offsite Document | OMB Report Pursuat to the Sequestration Transparency Act of 2012 (P.L. 112-155), 9/1/2012 - Source: Office of Management and Budget Adobe Acrobat PDF
|
| 5 | Document | Marsha Gold Presentation: What We Know From Analyzing Public Data Files, 5/19/2006 - Source: Mathematica Policy Research, Inc. (Adobe Acrobat PDF: 692 kb)
|
| 5 | Offsite Document | Details on Medicare Prescription Drug Deal Remain Murky, 7/13/2009 - Source: Commonwealth Fund (Unknown File Type)
|
| 5 | Offsite Document | Candidates Issue Index, 5/13/2008 - Source: The Brookings Institution (Unknown File Type)
|
| 5 | Offsite Document | American College of Cardiology Supports E-Prescription Mandate, 6/3/2008 - Source: iHealth Beat (Unknown File Type)
|